Improving medication adherence among community-dwelling seniors with cognitive impairment: a systematic review of interventions
The DOI matches its Crossref record; 67 of the 69 references it cites were found in a registry or an index.
Abstract
Background Medication non-adherence may lead to poor therapeutic outcomes. Cognitive functions deteriorate with age, contributing to decreased adherence. Interventions have been tested to improve adherence in seniors with cognitive impairment or Alzheimer disease (AD), but high-quality systematic reviews are lacking. It remains unclear which interventions are promising. Objectives We conducted a systematic review to identify, describe, and evaluate interventions aimed at improving medication adherence among seniors with any type of cognitive impairment. Methods Following NICE guidance, databases and websites were searched using combinations of controlled and free vocabulary. All adherence-enhancing interventions and study designs were considered. Studies had to include community dwelling seniors, aged 65 years or older, with cognitive impairment, receiving at least one medication for a chronic condition, and an adherence measure. Study characteristics and methodological quality were assessed. Results We identified 13 interventions, including six RCTs. Two studies were of poor, nine of low/medium and two of high quality. Seven studies had sample sizes below 50 and six interventions focused on adherence to AD medication. Six interventions tested a behavioral, four a medication oriented, two an educational and one a multi-faceted approach. Studies rarely assessed therapeutic outcomes. All but one intervention showed improved adherence. Conclusion Three medium quality studies sho…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but these studies did not focus on eHealth interventions.”
In the citing paper
“Also, there exist only two reviews of interventions designed for enhancing medication adherence among older adults with cognitive impairment,23 24”
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Canadian Institute for Health Information.
Lalonde, A. (1994) · PubMed · Cited by 4,739
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Adherence to Long‐Term Therapies: Evidence for Action
Burkhart, P. V., & Sabaté, E. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.tb00001.x · Cited by 2,526
(2015) · HAL · Cited by 2,238
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659
Guidance on the conduct of narrative synthesis in sytematic reviews
Popay, J., Roberts, H. M., Sowden, A. J., Petticrew, M. P., Arai, L., Rodgers, M., & Britten, N. (2006) · Cited by 1,378
The Diagnosis and Management of Mild Cognitive Impairment: A Clinical Review
Langa, K. M., & Levine, D. A. (2014) · JAMA · doi:10.1001/jama.2014.13806 · Cited by 1,337
Prevalence and severity of cognitive impairment with and without dementia in an elderly population
Graham, J. E., Rockwood, K., Beattie, B. L., Eastwood, R., Gauthier, S., Tuokko, H., & McDowell, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01007-6 · Cited by 999
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Tariq, S. H., Tumosa, N., Chibnall, J. T., Perry, M. H., & Morley, J. E. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000221510.33817.86 · Cited by 724
Patient adherence to medical treatment: a review of reviews
van Dulmen, S., Sluijs, E., van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-55 · Cited by 627
Mild cognitive impairment: Disparity of incidence and prevalence estimates
Ward, A., Arrighi, H. M., Michels, S., & Cedarbaum, J. M. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.01.002 · Cited by 569
Out-Of-Pocket Medical Spending For Care Of Chronic Conditions
Hwang, W., Weller, W., Ireys, H., & Anderson, G. (2001) · Health Affairs · doi:10.1377/hlthaff.20.6.267 · Cited by 440
Medication Non-Adherence in the Elderly: How Big is the Problem?
Hughes, C. M. (2004) · Drugs & Aging · doi:10.2165/00002512-200421120-00004 · Cited by 340
Current Epidemiology of Mild Cognitive Impairment and Other Predementia Syndromes
Panza, F., D’Introno, A., Colacicco, A. M., Capurso, C. A., Parigi, A. D., Caselli, R. J., Pilotto, A., Argentieri, G., Scapicchio, P. L., Scafato, E., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.8.633 · Cited by 310
Imaz, I., Zegarra, P., González-Enríquez, J., Rubio, B., Alcazar, R., & Amate, J. M. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1134-4 · Cited by 252
Adherence to Medication in Patients with Dementia: Predictors and Strategies for Improvement
Arlt, S., Lindner, R., Rösler, A., & von Renteln-Kruse, W. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00005 · Cited by 249
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russell, C. L. (2009) · The Gerontologist · doi:10.1093/geront/gnp037 · Cited by 227
Medication Adherence in Older Adults With Cognitive Impairment: A Systematic Evidence-Based Review
Campbell, N. L., Boustani, M. A., Skopelja, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.04.004 · Cited by 206
George, J., Elliott, R. A., & Stewart, D. C. (2008) · Drugs & Aging · doi:10.2165/00002512-200825040-00004 · Cited by 191
van Eijken, M., Tsang, S., Wensing, M., de Smet, P. A. G. M., & Grol, R. P. T. M. (2003) · Drugs & Aging · doi:10.2165/00002512-200320030-00006 · Cited by 184
Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community?
Okuno, J., Yanagi, H., & Tomura, S. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100347 · Cited by 168
Mild cognitive impairment and everyday functioning in older adults
Tuokko, H., Morris, C., & Ebert, P. (2005) · Neurocase · doi:10.1080/13554790490896802 · Cited by 148
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
Ross, S. D., Samuels, E. R., Gairy, K., Iqbal, S. U., Badamgarav, E., & Siris, E. S. (2011) · Value in Health · doi:10.1016/j.jval.2010.11.010 · Cited by 122
First do no harm: a real need to deprescribe in older patients
Scott, I. A., Anderson, K., Freeman, C. R., & Stowasser, D. A. (2014) · Medical Journal of Australia · doi:10.5694/mja14.00146 · Cited by 118
Benefits of deprescribing on patients’ adherence to medications
Reeve, E., & Wiese, M. D. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9871-z · Cited by 112
Medication use among senior Canadians.
Ramage-Morin, P. L. (2009) · PubMed · Cited by 112
Systematic reviews to evaluate diagnostic tests
Khan, K. S., Dinnes, J., & Kleijnen, J. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00463-2 · Cited by 108
A review of interventions used to improve adherence to medication in older people
Banning, M. (2009) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2009.03.011 · Cited by 98
Schlenk, E. A., Dunbar-Jacob, J., & Engberg, S. (2004) · Journal of Gerontological Nursing · doi:10.3928/0098-9134-20040701-08 · Cited by 95
Elders' Nonadherence: Its Assessment and Medication Reminding by Voice Mail
Leirer, V. O., Morrow, D. G., Tanke, E. D., & Pariante, G. M. (1991) · The Gerontologist · doi:10.1093/geront/31.4.514 · Cited by 95
Kripalani, S. B., Schmotzer, B. J., & Jacobson, T. A. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2136-z · Cited by 90
Telehealth Home Monitoring of Solitary Persons With Mild Dementia
Smith, G. E., Lunde, A. M., Hathaway, J. C., & Vickers, K. S. (2007) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317506295888 · Cited by 77
Effect of Statin Adherence on Cerebrovascular Disease in Primary Prevention
Perreault, S., Ellia, L., Dragomir, A., Côté, R., Blais, L., Bérard, A., & Lalonde, L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.032 · Cited by 75
Prevalence and Persistence of Mild Cognitive Impairment among Elderly Patients in General Hospitals
Bickel, H., Mösch, E., Seigerschmidt, E., Siemen, M., & Förstl, H. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000091397 · Cited by 66
Maxwell, C. J., Stock, K., Seitz, D., & Herrmann, N. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405901203 · Cited by 63
Kröger, E., Mouls, M., Wilchesky, M., Berkers, M., Carmichael, P.-H., van Marum, R., Souverein, P., Egberts, T., & Laroche, M.-L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015602274 · Cited by 58
Self-citationMedication Reminder Device for the Elderly Patients With Mild Cognitive Impairment
Kamimura, T., Ishiwata, R., & Inoue, T. (2012) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317512450066 · Cited by 55
Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes
Perreault, S., Yu, A. Y. X., Côté, R., Dragomir, A., White-Guay, B., & Dumas, S. (2012) · Neurology · doi:10.1212/wnl.0b013e3182749e56 · Cited by 53
Adler, G., Mueller, B., & Articus, K. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12374 · Cited by 47
Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer’s disease
Molinuevo, J. L., & Arranz, F. J. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.178 · Cited by 46
Ownby, R. L., Hertzog, C. K., & Czaja, S. J. (2012) · Clinical Gerontologist · doi:10.1080/07317115.2012.657294 · Cited by 44
Individualizing memory strategies to improve medication adherence
Insel, K. C., & Cole, L. (2005) · Applied Nursing Research · doi:10.1016/j.apnr.2004.08.007 · Cited by 42
Kröger, E., van Marum, R. J., Souverein, P. C., & Egberts, T. C. G. (2010) · Drugs & Aging · doi:10.2165/11538230-000000000-00000 · Cited by 30
Self-citationHawkins, L. A., & Firek, C. J. (2014) · Heart & Lung · doi:10.1016/j.hrtlng.2014.05.003 · Cited by 30
Tian, H., Abouzaid, S., Chen, W., Kahler, K. H., & Kim, E. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318266fb02 · Cited by 20
Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence
Yamamura, K., Suzuki, Y., Umegaki, Shigeno, K., Matsushita, R., Sai, Y., Miyamoto, K.-I., & Yamada, K. (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s34984 · Cited by 19
NON-ADHERENCE IN SENIORS WITH DEMENTIA – A SERIOUS PROBLEM OF ROUTINE CLINICAL PRACTICE
Lužný, J., Ivanová, K., & Juríčková, Ľ. (2014) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2014.43 · Cited by 11
Patients' perspectives on the brave new word ‘deprescribing’
Reeve, E., & Turner, J. P. (2015) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12111 · Cited by 11
The AHCPR Clinical Practice Guideline for Heart Failure Revisited
Adams, K. F., Ellis, M. L., WILLIAMSON, K. M., & Patterson, J. H. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101013 · Cited by 10
Research works printed but not linked: 2
- Oswald WD, Gunzelmann T, Wannenmacher W. Die Compliance von Patienten höheren Lebensalters mit Hirnleistungsstörungen bei Encephabol forte und Encephabol 600 [Compliance of patients with dementia syndrome treated with Encephabol forte and Encephabol 600]. Z Gerontopsychologie Psychiatr. 1993;6:17–25.
- Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16:CD000011.
Cited by
Ruangritchankul, S., Chantharit, P., Srisuma, S., & Gray, L. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s323387 · Cited by 162
Cardiovascular care of older adults
O’Neill, D. E., & Forman, D. E. (2021) · BMJ · doi:10.1136/bmj.n1593 · Cited by 63
How to manage comorbidities in people with dementia: A scoping review
Ma, D., Wang, Y., Zhao, Y., Meng, X., Su, J., Zhi, S., Song, D., Gao, S., Sun, J., & Sun, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101937 · Cited by 25
Marcum, Z. A., Walker, R. L., Jones, B. L., Ramaprasan, A., Gray, S. L., Dublin, S., Crane, P. K., & Larson, E. B. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1058-6 · Cited by 23
“[24] Comorbidity as measured by the Charlson score may be considered a proxy of medication regimen complexity.”
MethodOwsiany, M. T., Hawley, C. E., & Paik, J. M. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00804-8 · Cited by 17
“Consider consulting a geriatrics and/or home health team if patients are no longer able to manage their medications due to cognitive impairment, regardless of whether or not a family member or caregiver can do so [63, 67, 68].”
BackgroundMethodInfluential
Metadata
- Authors
- Kröger, E., Tatar, O., Vedel, I., Giguère, A. M. C., Voyer, P., Guillaumie, L., Grégoire, J.-P., & Guénette, L.
- Affiliations
- Hôpital du Saint-Sacrement (CA)
- McGill University (CA)
- Université Laval (CA)
- Corresponding author
- Kröger, Edeltraut
- ORCID
- Venue
- International Journal of Clinical Pharmacy
- Published
- 2017-05-29
- Volume
- 39
- Issue
- 4
- Pages
- 641-656
- ISSN
- 2210-7703 (ISSN-L)
- 2210-7711
- OpenAlex
- W2620431985
- Semantic Scholar
- 6edaeae93c593050b7fe6e17b96e3f57661a997b
- Cited by
- 23
- References
- 69
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 1
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Clinical Pharmacy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chaire sur l'adhésion aux traitements de l'Université Laval
- Centre d'excellence sur le vieillissement de Québec
- Réseau québécois de recherche sur le vieillissement du Fonds de recherche du Québec-Santé
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication adherence, cognitive impairment, Alzheimer's disease, older adults, community-dwelling older adults, adherence interventions, transdermal patch, medication reminders, patient education, behavioral interventions, chronic disease, methodological quality of trials
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Drug Administration Routes, Drug Administration Schedule, Humans, Randomized Controlled Trials as Topic, Drug Monitoring, Medication Adherence, Independent Living, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.